Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to 0.16.

  • Aytu Biopharma's Debt Ratio rose 2983.55% to 0.16 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.16, marking a year-over-year increase of 2983.55%. This contributed to the annual value of 0.16 for FY2025, which is 4301.15% up from last year.
  • Per Aytu Biopharma's latest filing, its Debt Ratio stood at 0.16 for Q4 2025, which was up 2983.55% from 0.2 recorded in Q3 2025.
  • Aytu Biopharma's 5-year Debt Ratio high stood at 0.2 for Q3 2025, and its period low was 0.06 during Q1 2021.
  • Moreover, its 5-year median value for Debt Ratio was 0.12 (2023), whereas its average is 0.12.
  • As far as peak fluctuations go, Aytu Biopharma's Debt Ratio soared by 88996.52% in 2021, and later tumbled by 2147.27% in 2023.
  • Over the past 5 years, Aytu Biopharma's Debt Ratio (Quarter) stood at 0.07 in 2021, then soared by 111.0% to 0.16 in 2022, then decreased by 21.47% to 0.12 in 2023, then dropped by 1.25% to 0.12 in 2024, then increased by 29.84% to 0.16 in 2025.
  • Its Debt Ratio stands at 0.16 for Q4 2025, versus 0.2 for Q3 2025 and 0.16 for Q2 2025.